[
  {
    "objectID": "2012_pain.html",
    "href": "2012_pain.html",
    "title": "1  Acute Pain Management in the Perioperative Setting (2012)",
    "section": "",
    "text": "Recommendation \n    Evidence \n  \n \n\n  \n    Pain assessment and therapy should be integrated into the perioperative care of geriatric patients. \n    Consensus statement \n  \n  \n    Pain assessment tools appropriate to a patient’s cognitive abilities should be used. Extensive and proactive evaluation and questioning may be necessary to overcome barriers that hinder communication regarding unrelieved pain. \n    Consensus statement \n  \n  \n    Anesthesiologists should recognize that geriatric patients may respond differently than younger patients to pain and analgesic medications, often because of comorbidity. \n    Consensus statement \n  \n  \n    Vigilant dose titration is necessary to ensure adequate treatment while avoiding adverse effects such as somnolence in this vulnerable group, who are often taking other medications (including alternative and complementary agents). \n    Consensus statement \n  \n\n\n\n Categories of evidence: \n\na Strength of evidence or category of recommentation"
  },
  {
    "objectID": "2012_pain.html#institutional-policies-and-procedures-for-providding-perioperative-pain-management",
    "href": "2012_pain.html#institutional-policies-and-procedures-for-providding-perioperative-pain-management",
    "title": "1  Acute Pain Management in the Perioperative Setting (2012)",
    "section": "1.2 Institutional Policies and Procedures for Providding Perioperative Pain Management",
    "text": "1.2 Institutional Policies and Procedures for Providding Perioperative Pain Management\n\n\n\n\n \n  \n    Recommendation \n    Evidence \n  \n \n\n  \n    Anesthesiologists offering perioperative analgesia services should provide, in collaboration with other healthcare professionals as appropriate, ongoing education and training to ensure that hospital personnel are knowledgeable and skilled with regard to the effective and safe use of the available treatment options within the institution. \n    B2 \n  \n  \n    Educational content should range from basic bedside pain assessment to sophisticated pain management techniques (e.g., epidural analgesia, PCA, and various regional anesthesia techniques) and nonpharmacologic techniques (e.g., relaxation, imagery, hypnotic methods). \n    B2 \n  \n  \n    For optimal pain management, ongoing education and training are essential for new personnel, to maintain skills, and whenever therapeutic approaches are modified. \n    B2 \n  \n  \n    Anesthesiologists and other healthcare providers should use standardized, validated instruments to facilitate the regular evaluation and documentation of pain intensity, the effects of pain therapy, and side effects caused by the therapy. \n    B2 \n  \n  \n    Anesthesiologists responsible for perioperative analgesia should be available at all times to consult with ward nurses, surgeons, or other involved physicians. \n    Consensus statement \n  \n  \n    They should assist in evaluating patients who are experiencing problems with any aspect of perioperative pain relief. \n    B2 \n  \n  \n    Anesthesiologists providing perioperative analgesia services should do so within the framework of an Acute Pain Service. \n    B2 \n  \n  \n    They should participate in developing standardized institutional policies and procedures. \n    Consensus statement \n  \n\n\n\n Categories of evidence: \n\na Strength of evidence or category of recommentation"
  },
  {
    "objectID": "2012_pain.html#multimodal-and-multidisciplinary-interventions",
    "href": "2012_pain.html#multimodal-and-multidisciplinary-interventions",
    "title": "1  Acute Pain Management in the Perioperative Setting (2012)",
    "section": "1.3 Multimodal and Multidisciplinary Interventions",
    "text": "1.3 Multimodal and Multidisciplinary Interventions\n\n\n\n\n \n  \n    Recommendation \n    Evidence \n  \n \n\n  \n    Multimodal interventions should be part of a treatment strategy for patients with chronic pain \n     \n  \n  \n    A long-term approach that includes periodic follow-up evaluations should be developed and implemented as part of the overall treatment strategy. \n     \n  \n\n\n\n Categories of evidence: \n\na Strength of evidence or category of recommentation"
  },
  {
    "objectID": "2012_pain.html#multimodal-techniques-for-pain-management",
    "href": "2012_pain.html#multimodal-techniques-for-pain-management",
    "title": "1  Acute Pain Management in the Perioperative Setting (2012)",
    "section": "1.4 Multimodal Techniques for Pain Management",
    "text": "1.4 Multimodal Techniques for Pain Management\n\n\n\n\n \n  \n    Recommendation \n    Evidence \n  \n \n\n  \n    Whenever possible, anesthesiologists should use multimodal pain management therapy. \n    A1 \n  \n  \n    Unless contraindicated, patients should receive an around-the-clock regimen of NSAIDs, COXIBs, or acetaminophen. \n    C2 \n  \n  \n    Regional blockade with local anesthetics should be considered. \n    Consensus statement \n  \n  \n    Dosing regimens should be administered to optimize efficacy while minimizing the risk of adverse events. \n    Consensus statement \n  \n  \n    The choice of medication, dose, route, and duration of therapy should be individualized. \n    Consensus statement \n  \n\n\n\n Categories of evidence: \n\na Strength of evidence or category of recommentation"
  },
  {
    "objectID": "2012_pain.html#other-patients",
    "href": "2012_pain.html#other-patients",
    "title": "1  Acute Pain Management in the Perioperative Setting (2012)",
    "section": "1.5 Other Patients",
    "text": "1.5 Other Patients\n\n\n\n\n \n  \n    Recommendation \n    Evidence \n  \n \n\n  \n    Anesthesiologists should recognize that patients who are critically ill, cognitively impaired, or have communication difficulties may require additional interventions to ensure optimal perioperative pain management. \n    D \n  \n  \n    Anesthesiologists should consider a therapeutic trial of an analgesic in patients with increased blood pressure and heart rate or agitated behavior when causes other than pain have been excluded. \n    D \n  \n\n\n\n Categories of evidence: \n\na Strength of evidence or category of recommentation"
  },
  {
    "objectID": "2012_pain.html#patient-evaluation",
    "href": "2012_pain.html#patient-evaluation",
    "title": "1  Acute Pain Management in the Perioperative Setting (2012)",
    "section": "1.6 Patient Evaluation",
    "text": "1.6 Patient Evaluation\n\n\n\n\n \n  \n    Recommendation \n    Evidence \n  \n \n\n  \n    Pain history should include a general medical history with emphasis on the chronology and symptomatology of the presenting complaints \n     \n  \n  \n    A history of current illness should include information about the onset, quality, intensity, distribution, duration, course, and sensory and affective components of the pain in addition to details about exacerbating and relieving factors. Additional symptoms (e.g., motor, sensory, and autonomic changes) should be noted. Information regarding previous diagnostic tests, results of previous therapies, and current therapies should be reviewed by the physician \n     \n  \n  \n    The causes and the effects of the pain (e.g., physical deconditioning, change in occupational status, and psychosocial dysfunction) and the impacts of previous treatment(s) should be evaluated and documented \n     \n  \n  \n    The physical examination should include an appropriately directed neurologic and musculoskeletal evaluation, with attention to other systems as indicated \n     \n  \n  \n    The psychosocial evaluation should include information about the presence of psychologic symptoms (e.g., anxiety, depression, or anger), psychiatric disorders, personality traits or states, and coping mechanisms. \n     \n  \n  \n    An assessment should be made of the impact of chronic pain on a patient’s ability to perform activities of daily living. An evaluation of the influence of pain and treatment on mood, ability to sleep, addictive or aberrant behavior, and interpersonal relationships should be performed. \n     \n  \n  \n    Evidence of family, vocational, or legal issues and involvement of rehabilitation agencies should be noted. \n     \n  \n  \n    The expectations of the patient, significant others, employer, attorney, and other agencies may also be considered.. \n     \n  \n  \n    The choice of an interventional diagnostic procedure (e.g., selective nerve root blocks, medial branch blocks, facet joint injections, sacroiliac joint injections, or provocative discography) should be based on the patient’s specific history and physical examination and the anticipated course of treatment. \n     \n  \n  \n    Interventional diagnostic procedures should be performed with appropriate image guidance. \n     \n  \n  \n    Diagnostic medial branch blocks or facet joint injections may be considered for patients with suspected facet-mediated pain to screen for subsequent therapeutic procedures. \n     \n  \n  \n    Diagnostic sacroiliac joint injections or lateral branch blocks may be considered for the evaluation of patients with suspected sacroiliac joint pain. \n     \n  \n  \n    Diagnostic selective nerve root blocks may be considered to further evaluate the anatomic level of radicular pain. \n     \n  \n  \n    The use of sympathetic blocks may be considered to support the diagnosis of sympathetically maintained pain. They should not be used to predict the outcome of surgical, chemical, or radiofrequency sympathectomy \n     \n  \n  \n    Peripheral blocks may be considered to assist in the diagnosis of pain in a specific peripheral nerve distribution. \n     \n  \n  \n    Provocative discography may be considered for the evaluation of selected patients with suspected discogenic pain; it should not be used for routine evaluation of a patient with chronic nonspecific back pain.. \n     \n  \n\n\n\n Categories of evidence: \n\na Strength of evidence or category of recommentation"
  },
  {
    "objectID": "2012_pain.html#pediatric-patients",
    "href": "2012_pain.html#pediatric-patients",
    "title": "1  Acute Pain Management in the Perioperative Setting (2012)",
    "section": "1.7 Pediatric Patients",
    "text": "1.7 Pediatric Patients\n\n\n\n\n \n  \n    Recommendation \n    Evidence \n  \n \n\n  \n    Aggressive and proactive pain management is necessary to overcome the historic undertreatment of pain in children. \n    Consensus statement \n  \n  \n    Perioperative care for children undergoing painful procedures or surgery requires developmentally appropriate pain assessment and therapy. \n    Consensus statement \n  \n  \n    Analgesic therapy should depend upon age, weight, and comorbidity, and unless contraindicated should involve a multimodal approach. \n    Consensus statement \n  \n  \n    Behavioral techniques, especially important in addressing the emotional component of pain, should be applied whenever feasible. \n    Consensus statement \n  \n  \n    Sedative, analgesic, and local anesthetics are all important components of appropriate analgesic regimens for painful procedures. \n    Consensus statement \n  \n  \n    Because many analgesic medications are synergistic with sedating agents, it is imperative that appropriate monitoring be used during the procedure and recovery. \n    Consensus statement \n  \n\n\n\n Categories of evidence: \n\na Strength of evidence or category of recommentation"
  },
  {
    "objectID": "2012_pain.html#perioperative-techniques-for-pain-management",
    "href": "2012_pain.html#perioperative-techniques-for-pain-management",
    "title": "1  Acute Pain Management in the Perioperative Setting (2012)",
    "section": "1.8 Perioperative Techniques for Pain Management",
    "text": "1.8 Perioperative Techniques for Pain Management\n\n\n\n\n \n  \n    Recommendation \n    Evidence \n  \n \n\n  \n    Anesthesiologists who manage perioperative pain should use therapeutic options such as epidural or intrathecal opioids, systemic opioid PCA, and regional techniques after thoughtfully considering the risks and benefits for the individual patient. \n    A2 \n  \n  \n    These modalities should be used in preference to intramuscular opioids ordered “as needed.” \n    Consensus statement \n  \n  \n    The therapy selected should reflect the individual anesthesiologist’s expertise, as well as the capacity for safe application of the modality in each practice setting. \n    Consensus statement \n  \n  \n    This capacity includes the ability to recognize and treat adverse effects that emerge after initiation of therapy. \n    Consensus statement \n  \n  \n    Special caution should be taken when continuous infusion modalities are used because drug accumulation may contribute to adverse events. \n    Consensus statement \n  \n\n\n\n Categories of evidence: \n\na Strength of evidence or category of recommentation"
  },
  {
    "objectID": "2012_pain.html#preoperative-evaluation-of-the-patient",
    "href": "2012_pain.html#preoperative-evaluation-of-the-patient",
    "title": "1  Acute Pain Management in the Perioperative Setting (2012)",
    "section": "1.9 Preoperative Evaluation of the Patient",
    "text": "1.9 Preoperative Evaluation of the Patient\n\n\n\n\n \n  \n    Recommendation \n    Evidence \n  \n \n\n  \n    A directed pain history, a directed physical examination, and a pain control plan should be included in the anesthetic preoperative evaluation. \n    D \n  \n\n\n\n Categories of evidence: \n\na Strength of evidence or category of recommentation"
  },
  {
    "objectID": "2012_pain.html#preoperative-preparation-of-the-patient",
    "href": "2012_pain.html#preoperative-preparation-of-the-patient",
    "title": "1  Acute Pain Management in the Perioperative Setting (2012)",
    "section": "1.10 Preoperative Preparation of the Patient",
    "text": "1.10 Preoperative Preparation of the Patient\n\n\n\n\n \n  \n    Recommendation \n    Evidence \n  \n \n\n  \n    Patient preparation for perioperative pain management should include appropriate adjustments or continuation of medications to avert an abstinence syndrome, treatment of preexistent pain, or preoperative initiation of therapy for postoperative pain management. \n    D \n  \n  \n    Anesthesiologists offering perioperative analgesia services should provide, in collaboration with others as appropriate, patient and family education regarding their important roles in achieving comfort, reporting pain, and in proper use of the recommended analgesic methods. \n    C2 \n  \n  \n    Common misconceptions that overestimate the risk of adverse effects and addiction should be dispelled. \n    Consensus statement \n  \n  \n    Patient education for optimal use of PCA and other sophisticated methods, such as patient-controlled epidural analgesia, might include discussion of these analgesic methods at the time of the preanesthetic evaluation, brochures and videotapes to educate patients about therapeutic options, and discussion at the bedside during postoperative visits. \n    Consensus statement \n  \n  \n    Such education may also include instruction in behavioral modalities for control of pain and anxiety. \n    Consensus statement \n  \n\n\n\n Categories of evidence: \n\na Strength of evidence or category of recommentation"
  },
  {
    "objectID": "2012_pain.html#single-modality-interventions",
    "href": "2012_pain.html#single-modality-interventions",
    "title": "1  Acute Pain Management in the Perioperative Setting (2012)",
    "section": "1.11 Single Modality Interventions",
    "text": "1.11 Single Modality Interventions\n\n\n\n\n \n  \n    Recommendation \n    Evidence \n  \n \n\n  \n    The Task Force notes that other treatment modalities should be attempted before consideration of the use of ablative techniques. \n     \n  \n  \n    Chemical denervation (e.g., alcohol, phenol, or high-concentration local anesthetics) should not be used in the routine care of patients with chronic noncancer pain. \n     \n  \n  \n    Cryoablation may be used in the care of selected patients (e.g., postthoracotomy pain syndrome, low back pain [medial branch], and peripheral nerve pain). \n     \n  \n  \n    IDET may be considered for young active patients with early single-level degenerative disc disease with well maintained disc height. \n     \n  \n  \n    Conventional (e.g., 80°C) or thermal (e.g., 67°C) radiofrequency ablation of the medial branch nerves to the facet joint should be performed for low back (me dial branch) pain when previous diagnostic or therapeutic injections of the joint or medial branch nerve have provided temporary relief. \n     \n  \n  \n    Conventional radiofrequency ablation may be performed for neck pain, and water-cooled radiofrequency ablation may be used for chronic sacroiliac joint pain. \n     \n  \n  \n    Conventional or thermal radiofrequency ablation of the dorsal root ganglion should not be routinely used for the treatment of lumbar radicular pain. \n     \n  \n  \n    Acupuncture may be considered as an adjuvant to conventional therapy (e.g., drugs, physical therapy, and exercise) in the treatment of nonspecific, noninflammatory low back pain. \n     \n  \n  \n    Intraarticular facet joint injections may be used for symptomatic relief of facet-mediated pain. \n     \n  \n  \n    Sacroiliac joint injections may be considered for symptomatic relief of sacroiliac joint pain. \n     \n  \n  \n    Celiac plexus blocks using local anesthetics with or without steroids may be used for the treatment of pain secondary to chronic pancreatitis. \n     \n  \n  \n    Lumbar sympathetic blocks or stellate ganglion blocks may be used as components of the multimodal treatment of CRPS if used in the presence of consistent improvement and increasing duration of pain relief. \n     \n  \n  \n    Sympathetic nerve blocks should not be used for long-term treatment of non-CRPS neuropathic pain. \n     \n  \n  \n    Medial branch blocks may be used for the treatment of facet-mediated spine pain. \n     \n  \n  \n    Peripheral somatic nerve blocks should not be used for long-term treatment of chronic pain. \n     \n  \n  \n    Botulinum toxin should not be used in the routine care of patients with myofascial pain. \n     \n  \n  \n    Botulinum toxin may be used as an adjunct for the treatment of piriformis syndrome. \n     \n  \n  \n    Subcutaneous peripheral nerve stimulation may be used in the multimodal treatment of patients with painful peripheral nerve injuries who have not responded to other therapies. \n     \n  \n  \n    Spinal cord stimulation may be used in the multimodal treatment of persistent radicular pain in patients who have not responded to other therapies. It may also be considered for other selected patients (e.g., those with CRPS, peripheral neuropathic pain, peripheral vascular disease, or postherpetic neuralgia). \n     \n  \n  \n    Shared decision making regarding spinal cord stimulation should include a specific discussion of potential complications associated with spinal cord stimulator placement. \n     \n  \n  \n    A spinal cord stimulation trial should be performed before considering permanent implantation of a stimulation device. \n     \n  \n  \n    TENS should be used as part of a multimodal approach to pain management for patients with chronic back pain and may be used for other pain conditions (e.g., neck and phantom limb pain). \n     \n  \n  \n    Epidural steroid injections with or without local anesthetics may be used as part of a multimodal treatment regimen to provide pain relief in selected patients with radicular pain or radiculopathy. \n     \n  \n  \n    Shared decision making regarding epidural steroid injections should include a specific discussion of potential complications, particularly with regard to the transforaminal approach. \n     \n  \n  \n    Transforaminal epidural injections should be performed with appropriate image guidance to confirm correct needle position and spread of contrast before injecting a therapeutic substance; image guidance may be considered for interlaminar epidural injections. \n     \n  \n  \n    Intrathecal neurolytic blocks should not be performed in the routine management of patients with noncancer pain. \n     \n  \n  \n    Intrathecal preservativefree steroid injections may be used for the relief of intractable postherpetic neuralgia nonresponsive to previous therapies. \n     \n  \n  \n    Ziconotide infusion may be used in the treatment of a select subset of patients with refractory chronic pain. \n     \n  \n  \n    Intrathecal opioid injection or infusion may be used for patients with neuropathic pain. \n     \n  \n  \n    Shared decision making regarding intrathecal opioid injection or infusion should include a specific discussion of potential complications. \n     \n  \n  \n    Neuraxial opioid trials should be performed before considering permanent implantation of intrathecal drug delivery systems. \n     \n  \n  \n    Minimally invasive spinal procedures may be used for the treatment of pain related to vertebral compression fractures. \n     \n  \n  \n    Anticonvulsants (e.g., _-2-delta calcium-channel antagonists, sodium-channel antagonists, and membrane-stabilizing drugs) should be used as part of amultimodal strategy for patients with neuropathic pain. \n     \n  \n  \n    Tricyclic antidepressants and serotonin–norepinephrine reuptake inhibitors should be used as part of a multimodal strategy for a variety of patients with chronic pain. \n     \n  \n  \n    Selective serotonin reuptake inhibitors may be considered specifically for patients with diabetic neuropathy. \n     \n  \n  \n    As part of a multimodal pain management strategy, extended-release oral opioids should be used for neuropathic or back pain patients, and transdermal, sublingual, and immediate-release oral opioids may be used. \n     \n  \n  \n    For selected patients, NMDA (ionotropic) receptor antagonists (e.g., neuropathic pain), NSAIDs (e.g., back pain), and topical agents (e.g., peripheral neuropathic pain) may be used, and benzodiazepines and skeletal muscle relaxants may be considered. \n     \n  \n  \n    A strategy for monitoring and managing side effects, adverse effects, and compliance should be in place before prescribing any long-term pharmacologic therapy. \n     \n  \n  \n    Physical or restorative therapy may be used as part of a multimodal strategy for patients with low back pain and may be considered for other chronic pain conditions. \n     \n  \n  \n    Cognitive behavioral therapy, biofeedback, or relaxation training: These interventions may be used as part of a multimodal strategy for low back pain and for other chronic pain conditions. \n     \n  \n  \n    Supportive psychotherapy, group therapy, or counseling: These interventions may be considered as part of a multimodal strategy for chronic pain management. \n     \n  \n  \n    Trigger point injections may be considered for treatment of patients with myofascial pain as part of a multimodal approach to pain management. \n     \n  \n\n\n\n Categories of evidence: \n\na Strength of evidence or category of recommentation"
  },
  {
    "objectID": "summary.html",
    "href": "summary.html",
    "title": "2  Summary",
    "section": "",
    "text": "1 + 1\n\n[1] 2"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Practice Parameter Recommendations",
    "section": "",
    "text": "Recommendations from the practice parameters. Note that the “Evidence” rating schemes (strength of evidence) may differ across practice parameters and defined accordingly for each."
  },
  {
    "objectID": "2012_pain.html#evidence-rating-scheme",
    "href": "2012_pain.html#evidence-rating-scheme",
    "title": "1  Acute Pain Management in the Perioperative Setting (2012)",
    "section": "1.12 Evidence Rating Scheme",
    "text": "1.12 Evidence Rating Scheme\nCategory A: Supportive Literature Randomized controlled trials report statistically significant (P < 0.01) differences between clinical interventions for a specified clinical outcome.\nLevel 1: The literature contains multiple RCTs, and aggregated findings are supported by meta-analysis.\nLevel 2: The literature contains multiple RCTs, but the number of studies is insufficient to conduct a viable meta-analysis for the purpose of the Guidelines.\nLevel 3: The literature contains a single randomized controlled trial.\nCategory B: Suggestive Literature Information from observational studies permits inference of beneficial or harmful relationships among clinical interventions and clinical outcomes.\nLevel 1: The literature contains observational comparisons (e.g., cohort, case-control research designs) of clinical interventions or conditions and indicates statistically significant differences between clinical interventions for a specified clinical outcome.\nLevel 2: The literature contains noncomparative observational studies with associative (e.g., relative risk, correlation) or descriptive statistics.\nLevel 3: The literature contains case reports.\nCategory C: Equivocal Literature The literature cannot determine whether there are beneficial or harmful relationships among clinical interventions and clinical outcomes.\nLevel 1: Meta-analysis did not find significant differences (P > 0.01) among groups or conditions.\nLevel 2: The number of studies is insufficient to conduct meta-analysis, and (1) RCTs have not found significant differences among groups or conditions or (2) RCTs report inconsistent findings.\nLevel 3: Observational studies report inconsistent findings or do not permit inference of beneficial or harmful relationships.\nCategory D: Insufficient Evidence from Literature The lack of scientific evidence in the literature is described by the following terms.\nInadequate: The available literature cannot be used to assess relationships among clinical interventions and clinical outcomes. The literature either does not meet the criteria for content as defined in the “Focus” of the Guidelines or does not permit a clear interpretation of findings due to methodological concerns (e.g., confounding in study design or implementation).\nSilent: No identified studies address the specified relationships among interventions and outcomes."
  }
]